Drug Approvals

FDA Approves CardioShield: First Drug for HFpEF Treatment

FDA · Heart Failure · 5 min

FDA Approves VitaCorp Antibiotic: Breakthrough for Multi-Drug Resistant Infections

FDA · Infectious Diseases · 7 min

FDA Approves NeuroVance XR: New Pediatric ADHD Extended-Release Option

FDA · Attention Deficit Hyperactivity Disorder (ADHD) · 6 min

FDA Approval TRK Inhibitor: OncoCure's Breakthrough for NTRK Tumors

FDA · Oncology · 4 min

FDA Approves RenoProtect: New Therapy to Slow Diabetic Kidney Disease

FDA · Diabetic Kidney Disease · 6 min

FDA Approves AirFlow: New Inhalable Treatment for Severe Asthma

FDA · Severe asthma · 6 min

FDA Approves ArterioFlow: Minimally Invasive PAD Treatment by CardioMed

FDA · Peripheral Artery Disease · 6 min

FDA Approves OptiSight: New VisionCare Glaucoma Treatment

FDA · Glaucoma · 6 min

FDA Approves MicroBalance: New Microbiome Therapy for Crohn's Disease

FDA · Crohn's disease · 6 min

FDA Approves NeuroBloc: Non-Opioid Relief for Chronic Neuropathic Pain

FDA · Chronic Neuropathic Pain · 6 min

FDA Approves BriaCell's Bria-IMT: Novel CAR-T Therapy for Advanced Breast Cancer

FDA · Breast Cancer · 4 min

FDA Approves Higher-Dose Wegovy 7.2mg for Weight Loss Under Priority Review Program

FDA · obesity/weight management · 3 min